Chinese authorities have filed charges against Leon Wang, who previously led AstraZeneca’s operations in China, Reuters reported.
Wang was taken into custody in October 2024 during investigations into the company’s activities in the country. He had served both as president of AstraZeneca China and as executive vice president responsible for international operations.
In its fourth-quarter 2025 results, AstraZeneca stated that Chinese prosecutors had brought charges in November against a former executive vice president and a former senior employee, without identifying them at the time.
The company later confirmed to Reuters that Wang was among those charged.
According to AstraZeneca, the charges include “unlawful collection of personal information, illegal trade and medical insurance fraud,” the company told Reuters.
